Understanding the proteins involved in Polycystic Kidney Disease
Structural Mechanisms of Polycystic Kidney Disease Proteins
This study is looking at how certain proteins important for kidney health work and fit together, which could help us understand and treat autosomal dominant polycystic kidney disease (ADPKD) better, so patients like you can have more options for managing the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11141713 on NIH RePORTER |
What this research studies
This research investigates the structural mechanisms of polycystin proteins, which are crucial for kidney function and are implicated in autosomal dominant polycystic kidney disease (ADPKD). By examining how these proteins assemble and function, the research aims to uncover their roles in kidney architecture and disease progression. The study utilizes advanced biochemical assays and cellular models to analyze the interactions and signaling pathways of these proteins. Patients with ADPKD may benefit from insights gained into the disease mechanisms and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with autosomal dominant polycystic kidney disease.
Not a fit: Patients with other forms of kidney disease unrelated to polycystin proteins may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and management strategies for patients with autosomal dominant polycystic kidney disease.
How similar studies have performed: Previous research has shown promising results in understanding polycystin proteins, but this study aims to explore novel aspects of their structure and function.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Cao, Erhu — University of Utah
- Study coordinator: Cao, Erhu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.